Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: analysis of a UK-based population. - Waddell T; Pillai M; Armitage K; Graham DM; Moran M; Dilleen M; Holmes S; Śleszyńska-Dopiera E; Hawkins R (Future oncology (London, England), 2024)